Innovex International, Inc.
INVX· NYSE
INVXInnovex International, Inc.
Filed Feb 27, 2024 · 10-K · 58 days after period end · 0000950170-24-020662
derived · Computed from the longer spans the company filed.
| Metric | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 |
|---|---|---|---|---|
| Revenue | $235.98M | $233.52M | $68.08M | $87.23M |
| Net Income | $52.77M | $64.50M | -$63.93M | -$11.25M |
| EPS Diluted | — | — |
Innovex International, Inc. · CIK 1042893 · Engraved from SEC EDGAR
| — |
| -$0.33 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ended Dec 31, 2023 · filed Feb 27, 2024 · 58 d after period end
